Biocurious: Shaken but not deterred after stroke of misfortune, Argenica’s 007 seeks licence to thrill

Stroke drug developer Argenica Therapeutics is planning a second trial to test its novel candidate, in a sector that has ... Read More The post Biocurious: Shaken but not deterred after stroke of misfortune, Argenica’s 007 seeks licence to thrill appeared first on Stockhead .

Go to News Site